相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Functional Analysis of DNMT3A DNA Methyltransferase Mutations Reported in Patients with Acute Myeloid Leukemia
Daria A. Khrabrova et al.
BIOMOLECULES (2020)
The design and development of covalent protein-protein interaction inhibitors for cancer treatment
Sha-Sha Cheng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners
Jonathan E. Sandoval et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Emerging roles of allosteric modulators in the regulation of protein-protein interactions (PPIs): A new paradigm for PPI drug discovery
Duan Ni et al.
MEDICINAL RESEARCH REVIEWS (2019)
DNA methyltransferases: emerging targets for the discovery of inhibitors as potent anticancer drugs
Jie Yu et al.
DRUG DISCOVERY TODAY (2019)
The R882H substitution in the human de novo DNA methyltransferase DNMT3A disrupts allosteric regulation by the tumor supressor p53
Jonathan E. Sandoval et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Mutations of R882 change flanking sequence preferences of the DNA methyltransferase DNMT3A and cellular methylation patterns
Max Emperle et al.
NUCLEIC ACIDS RESEARCH (2019)
The timeline of epigenetic drug discovery: from reality to dreams
A. Ganesan et al.
CLINICAL EPIGENETICS (2019)
Oncogenic Roles and Inhibitors of DNMT1, DNMT3A, a DNMT3B in Acute Myeloid Leukaemia
Kah Keng Wong et al.
BIOMARKER INSIGHTS (2019)
The DNA methyltransferase family: a versatile toolkit for epigenetic regulation
Frank Lyko
NATURE REVIEWS GENETICS (2018)
Targeting a Subpocket in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) Enables the Structure-Based Discovery of Selective Inhibitors with Trypanocidal Activity
Antoni R. Blaazer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Structural basis for DNMT3A-mediated de novo DNA methylation
Zhi-Min Zhang et al.
NATURE (2018)
DNMT3A in Leukemia
Lorenzo Brunetti et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Conserved motif VIII of murine DNA methyltransferase Dnmt3a is essential for methylation activity
Olga V. Lukashevich et al.
BMC BIOCHEMISTRY (2016)
Controlling Allosteric Networks in Proteins
Nikolay V. Dokholyan
CHEMICAL REVIEWS (2016)
Role of TET enzymes in DNA methylation, development, and cancer
Kasper Dindler Rasmussen et al.
GENES & DEVELOPMENT (2016)
Allosteric control of mammalian DNA methyltransferases - a new regulatory paradigm
Albert Jeltsch et al.
NUCLEIC ACIDS RESEARCH (2016)
Drugs for Allosteric Sites on Receptors
Cody J. Wenthur et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54 (2014)
The R882H DNMT3A Mutation Associated with AML Dominantly Inhibits Wild-Type DNMT3A by Blocking Its Ability to Form Active Tetramers
David A. Russler-Germain et al.
CANCER CELL (2014)
The essential roles of chemistry in high-throughput screening triage
Jayme L. Dahlin et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Selective Non-nucleoside Inhibitors of Human DNA Methyltransferases Active in Cancer Including in Cancer Stem Cells
Sergio Valente et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
New concepts in DNA methylation
Albert Jeltsch et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Identification of Novel Inhibitors of DNA Methylation by Screening of a Chemical Library
Alexandre Ceccaldi et al.
ACS CHEMICAL BIOLOGY (2013)
DNA methylation dynamics in health and disease
Yehudit Bergman et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
DNA methylation inhibitors in cancer: Recent and future approaches
Christina Gros et al.
BIOCHIMIE (2012)
Mutations in DNA Methyltransferase (DNMT3A) Observed in Acute Myeloid Leukemia Patients Disrupt Processive Methylation
Celeste Holz-Schietinger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Catechol Pyrazolinones as Trypanocidals: Fragment-Based Design, Synthesis, and Pharmacological Evaluation of Nanomolar Inhibitors of Trypanosomal Phosphodiesterase B1
Kristina M. Orrling et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Exploring and exploiting allostery: Models, evolution, and drug targeting
Alessio Peracchi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2011)
A decade of exploring the cancer epigenome - biological and translational implications
Stephen B. Baylin et al.
NATURE REVIEWS CANCER (2011)
A New Class of Quinoline-Based DNA Hypomethylating Agents Reactivates Tumor Suppressor Genes by Blocking DNA Methyltransferase 1 Activity and Inducing Its Degradation
Jharna Datta et al.
CANCER RESEARCH (2009)
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Mamta Tahiliani et al.
SCIENCE (2009)
Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
Carlo Stresemann et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Discovery of two novel, small-molecule inhibitors of DNA methylation
P Siedlecki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
The Dnmt1 DNA-(cytosine-C5)-methyltransferase methylates DNA processively with high preference for hemimethylated target sites
A Hermann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Prokaryotic DNA methyltransferases: The structure and the mechanism of interaction with DNA
ES Gromova et al.
MOLECULAR BIOLOGY (2003)
Preferential methylation of unmethylated DNA by mammalian de novo DNA methyltransferase Dnmt3a
T Yokochi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
分享论文
